A. M. Verkerk

Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.

T. H. van der Kwast, W. Hop, F. Schröder, 1997, Laboratory investigation; a journal of technical methods and pathology.

QUALITY OF LIFE EFFECTS OF INTERMITTENT AND CONTINUOUS HORMONAL THERAPY BY CYPROTERONE ACETATE (CPA) FOR METASTATIC PROSTATE CANCER

F. Schröder, P. Verhagen, C. Bangma, 2008 .

Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial

P. Verhagen, C. Bangma, G. Mickisch, 2014, World Journal of Urology.